Penn Engineering’s Nader Engheta Receives the Benjamin Franklin Medal for his work on metamaterials
Engheta was granted this prestigious award, which is one of the world’s oldest science and technology awards, for his transformative innovations in engineering novel metamaterials.
New Approaches to CAR-T Therapy
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
Penn Dental Medicine and Penn Engineering Faculty Invent Nanorobotic system That Offers new options for targeting fungal infections
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Penn Dental Medicine Researchers Develop Plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.
Philadelphia Life Sciences Jobs Being Filled More by Women Than Men, Study Finds
The number of jobs held by women in the Philadelphia region's life sciences industry is growing at a faster rate than jobs held by men, according to a new report featured in the Philadelphia Business
Future mRNA Vaccine Applications Highlighted
The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, and more.
Penn Startups Win Several PACT Enterprise Awards
viTToria Biotherapeutics and Exyn Technologies, both startups co-founded by Penn faculty, won recent awards from the Philadelphia Alliance for Capital and Technologies.
4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics
Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).
Adult Schizophrenia Drug Wins FDA Approval
Teva Pharmaceuticals and MedinCell recently received approval from the U.S. Food and Drug Administration (FDA) for UZEDY™ (risperidone).
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201 Drug to Target Autoimmune Diseases
Cabaletta Bio received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug CABA-201.